StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.00+0.00 (0.00%)

Close on Nov 20, 2026Market cap $3.21BP/E –Yield –

BGM free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$3.94M, down 1395.3% from the year before. The highest annual figure on record is $10.62M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$3.94M-1395.3%
FY2024Sep 30, 2024$304.11K+129.6%
FY2023Sep 30, 2023$132.45K-98.8%
FY2022Sep 30, 2022$10.62M–
FY2021Sep 30, 2021-$1.15M-124.8%
FY2020Sep 30, 2020$4.63M–
FY2019Sep 30, 2019-$1.20M-136.0%
FY2018Sep 30, 2018$3.32M–

More BGM figures

See a number that looks wrong?